These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2884116)

  • 1. Effects of bisoprolol on blood pressure, serum lipids and HDL-cholesterol in essential hypertension.
    Frithz G; Weiner L
    Eur J Clin Pharmacol; 1987; 32(1):77-80. PubMed ID: 2884116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effects of bisoprolol on blood pressure, serum lipids, and HDL-cholesterol in patients with essential hypertension.
    Frithz G; Weiner L
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S134-8. PubMed ID: 2439784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of carvedilol on serum lipids in patients with essential hypertension.
    Goto Y; Tamachi H; Fusegawa Y; Nakaya N; Homma Y; Mikami M; Iori S; Yamazaki A
    J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S45-50. PubMed ID: 1721979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-effect relationship and long-term effects of bisoprolol in mild to moderate hypertension.
    Weiner L; Frithz G
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S106-12. PubMed ID: 2439780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of carvedilol on serum lipids in hypertensive and normotensive subjects.
    Seguchi H; Nakamura H; Aosaki N; Homma Y; Mikami Y; Takahashi S
    Eur J Clin Pharmacol; 1990; 38 Suppl 2():S139-42. PubMed ID: 1974504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of bevantolol and propranolol on serum lipids in patients with essential hypertension.
    Sasaki J; Kajiyama G; Kusukawa R; Mori H; Koga S; Takagi R; Tanaka N; Ogawa N; Arakawa K
    Int J Clin Pharmacol Ther; 1994 Dec; 32(12):660-4. PubMed ID: 7881705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of arotinolol on serum lipid and apolipoprotein levels in patients with mild essential hypertension.
    Sasaki J; Handa K; Arakawa K
    Clin Ther; 1989; 11(5):580-3. PubMed ID: 2478285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma lipids during chronic antihypertensive therapy with different beta-blockers.
    Fogari R; Zoppi A; Pasotti C; Poletti L; Tettamanti F; Malamani G; Corradi L
    J Cardiovasc Pharmacol; 1989; 14 Suppl 7():S28-32. PubMed ID: 2481787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisoprolol versus hydrochlorothiazide plus amiloride in essential hypertension, a randomized double-blind study.
    Honoré P
    Eur Heart J; 1987 Dec; 8 Suppl M():95-102. PubMed ID: 2897305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of bisoprolol in patients with hypertension: interim report.
    Ikeda M; Inagaki Y; Iimura O; Kuramoto K; Takeda T
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S139-42. PubMed ID: 2439785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid profile improvement following celiprolol.
    Herrmann JM; von Heyman F; Freischütz G
    J Int Med Res; 1988; 16 Suppl 1():39A-46A. PubMed ID: 2906016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the effects of bisoprolol and atenolol on lipoprotein concentrations and blood pressure.
    Lithell H; Weiner L; Selinus I; Vessby B
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S128-33. PubMed ID: 2439783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of bucindolol on plasma HDL cholesterol subfractions and other plasma lipids in essential hypertensive patients.
    Lehtonen A; Tanskanen A; Temmerman J
    Int J Clin Pharmacol Ther Toxicol; 1987 Aug; 25(8):448-51. PubMed ID: 2888737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind comparison of bisoprolol and captopril for treatment of essential hypertension in the elderly.
    Bracchetti D; Gradnik R; Alberti A; Brunelli A; Orselli L; Leonardi G; Pavesi PC; Cantelli I
    Cardiovasc Drugs Ther; 1990 Feb; 4(1):261-4. PubMed ID: 1981017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive effects of bisoprolol during once daily administration in patients with essential hypertension. A dose-ranging study with parallel groups.
    Weiner L; Frithz G
    Eur J Clin Pharmacol; 1986; 29(5):517-21. PubMed ID: 2869951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of bisoprolol, a beta 1-selective beta-blocker, on lipid and glucose metabolism and quality of life in elderly patients with essential hypertension].
    Haneda T; Ido A; Fujikane T; Tanaka H; Tanazawa S; Morimoto H; Kato J; Kanaya K; Honda H; Sakai H; Akita N; Hirayama T; Onodera S; Kikuchi K
    Nihon Ronen Igakkai Zasshi; 1998 Jan; 35(1):33-8. PubMed ID: 9564739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of bisoprolol on blood pressure and arterial hemodynamics in systemic hypertension.
    Asmar RG; Kerihuel JC; Girerd XJ; Safar ME
    Am J Cardiol; 1991 Jul; 68(1):61-4. PubMed ID: 1676238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of bisoprolol and atenolol in the treatment of mild to moderate hypertension.
    Lewis R; Maclean D; Ioannides C; Johnston A; McDevitt DG
    Br J Clin Pharmacol; 1988 Jul; 26(1):53-9. PubMed ID: 2904825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of talinolol and atenolol effects on blood pressure in relation to lipid and glucose metabolic parameters. Results from the TALIP study.
    Sourgens H; Schmidt J; Derendorf H
    Int J Clin Pharmacol Ther; 2003 Jan; 41(1):22-9. PubMed ID: 12564742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three years of experience with bisoprolol in the treatment of mild to moderate hypertension.
    Giesecke HG; Buchner-Möll D
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S175-8. PubMed ID: 11527123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.